Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Thrombocytosis 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1

Interventions

Trastuzumab 4 pyrotinib 3 Vinorelbine 2 pertuzumab 1 copanlisib 1 Lapatinib 1 Docetaxel 1 Carboplatin 1 Capecitabine 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

HER2 Positive Breast Cancer × copanlisib × Breast × Clear all

NCT02705859 2026-04-13

Panther

Cancer Trials Ireland

Phase 1 Completed

HER2 Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡